Article Information
History
- October 19, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jing Yang1,2,4,5,+,
- Zhilong Jia3,4,5,+,*,
- Xinyu Song3,4,
- Jinlong Shi2,4,
- Xiaojing Zhao5,6 and
- Kunlun He1,2,4,5,*
- 1Medical School of Chinese PLA, Chinese PLA General Hospital, Beijing, China, 100853
- 2Research Center for Medical Big Data, Medical Innovation Research Division Of Chinese PLA General Hospital, Beijing, China, 100853
- 3Center for Artificial Intelligence in Medicine, Medical Innovation Research Division Of Chinese PLA General Hospital, Beijing, China, 100853
- 4Key Laboratory of Biomedical Engineering and Translational Medicine, Ministry of Industry and Information Technology, Chinese PLA General Hospital, Beijing, China, 100853
- 5Beijing Key Laboratory of Chronic Heart Failure Precision Medicine, Chinese PLA General Hospital, Beijing, China, 100853
- 6Translational Medicine Research Center, Medical Innovation Research Division Of Chinese PLA General Hospital, Beijing, China, 100853
- ↵*Corresponding authors: Kunlun He (kunlunhe{at}plagh.org) and Zhilong Jia (jiazhilong{at}plagh.org)
↵+ These authors contributed equally.
Posted October 19, 2021.
Proteomic and clinical biomarkers for acute mountain sickness diagnosis, prognosis, protection, and pathogenesis in a longitudinal cohort
